Paces Ferry Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Paces Ferry Wealth Advisors, LLC
- $187 Million
- Q1 2025
A detailed history of Paces Ferry Wealth Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Paces Ferry Wealth Advisors, LLC holds 520 shares of REGN stock, worth $254,945. This represents 0.18% of its overall portfolio holdings.
Number of Shares
520
Previous 453
14.79%
Holding current value
$254,945
Previous $322,000
2.17%
% of portfolio
0.18%
Previous 0.16%
Shares
19 transactions
Others Institutions Holding REGN
# of Institutions
1,471Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.61 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.14 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.77 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.35 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$1.96 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $52.6B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...